Learn how to navigate antitrust challenges to biological products (“biologics”) in view of the rapidly evolving legal landscape. With the COVID-19 pandemic ongoing, and the 2020 election ahead, the high prices of life-saving biologics are a central focus of political attention, and biologics companies are under increasing risk of antitrust liability from new litigation challenges and bipartisan legislative proposals.
Learn about recent developments and future trends that are shaping the landscape for what innovator biologics companies can and can’t do to protect their products from biosimilar competition. We break down the potential changes ahead, and discuss strategies for biologics companies to plan for the future.
Wednesday, October 28
1:00 P.M. – 2:00 P.M. ET
If you have questions concerning this roundtable webinar, email firstname.lastname@example.org.
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, email@example.com. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.
General information on our practice is available in our electronic publications Serving the Life Sciences Industry and Serving the Healthcare Industry. If you would like to be included on our regular pharmaceutical manufacturers, medical device manufacturers or healthcare provider mailing lists to receive notices of other events and written updates, you can be added by submitting your full contact information to firstname.lastname@example.org and specifying the list you wish to join.